Needham Investment Management’s Core Laboratories CLB Stock Holding History

Needham Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,000	Closed	-$414K	–	84
2019 Q1	$414K	Hold	6,000	–	–	0.14%	66
2018 Q4	$358K	Buy	+6,000	New	+$518K	0.13%	69
2018 Q1	–	Sell	-500	Closed	-$55K	–	92
2017 Q4	$55K	Sell	500 -5,500	-92%	-$549K	0.01%	91
2017 Q3	$592K	Sell	6,000 -3,000	-33%	-$291K	0.15%	73
2017 Q2	$912K	Hold	9,000	–	–	0.24%	64
2017 Q1	$1.04M	Buy	9,000 +2,500	+38%	+$291K	0.27%	62
2016 Q4	$780K	Buy	+6,500	New	+$720K	0.2%	74

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Needham Investment Management's CLB Position: Q2 2019 in Review

Needham Investment Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 6,000 shares — an estimated $414K sold.

Needham Investment Management first reported a position in CLB in Q4 2016 and held it in 7 quarters. The position peaked at $1.04M in Q1 2017. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Needham Investment Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Needham Investment Management sold 6,000 Core Laboratories shares in Q2 2019, an estimated $414K.
Needham Investment Management first reported a position in Core Laboratories in Q4 2016 and held it in 7 quarters.
Needham Investment Management's Core Laboratories position peaked at $1.04M in Q1 2017.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Needham Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.